معرفی
Dariush Daneshvar is a Clinical Lecturer at the Sydney Medical School, affiliated with the Faculty of Medicine and Health at the University of Sydney. His research focuses on biomarkers and mechanisms of resistance in cancer therapies, particularly for lung and melanoma cancers.
- University: University of Sydney
- School: Sydney Medical School
- Email: dariush.daneshvar@sydney.edu.au
Dr. Daneshvar's research interests center on oncology and cancer biology, with a focus on predictive biomarkers for chemotherapy efficacy and resistance. His work explores the roles of molecules like Activin-A, Growth Differentiation Factor-11, and Transforming Growth Factor-β in platinum chemotherapy responses and investigates molecular diagnostics for melanoma treatment strategies.
Recent publications highlight his contributions to lung adenocarcinoma resistance mechanisms, melanoma biomarker-guided therapies, and real-world applications of immunotherapy in malignant mesothelioma. These studies span translational research, pharmacology, and clinical oncology.
Dr. Daneshvar collaborates extensively across multidisciplinary teams, including medical oncologists, pathologists, and researchers in lung cancer and melanoma fields.
